Golden Door Asset

The Software Brief · Application

Vertex

VERX

$11.06

−2.73% · −0.31

Desk note

Library

No desk note yet. The price line below is only the recap.

Vertex (VERX) is down 2.73% at $11.06. It sits in the application software book. The wire: Vertex opens up larger kidney disease opportunity with mid-stage readout.

The copy

  1. BioSpace · 6d agoVertex opens up larger kidney disease opportunity with mid-stage readout
  2. Yahoo! Finance Canada · 3d agoVertex Pharmaceuticals Incorporated (VRTX) Stock Price, News, Quote & History
  3. Fierce Biotech · 6d agoVertex’s midstage data amplify kidney disease market opportunity
  4. Fierce Pharma · Sep 15Olympic skier Lindsey Vonn joins up with Vertex for pain campaign
  5. fortune.com · 4d agoVertex Pharmaceuticals (VRTX) Q1 2026 Earnings Call Transcript
  6. Men's Journal · 4d agoJames Bond Just Ditched His Iconic Omega Watch for Something Entirely Different—and It's Selling Fast
  7. The Manual · 2d agoWe have a new James Bond watch, and it is finally the perfect choice
  8. Crunchyroll · Sep 18VERTEX FORCE Anime Shares Creditless Opening Sequence Video

Delayed quotes. Not investment advice. Back to the tape